RxDoctor Payments Data

Stanley Hertz, MD

Psychiatry · Roslyn, NYNPI 1821166158

Payments from drug & device makers

$5,699in general payments, 2019–2025

Across 288 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$2K
  • Lundbeck LLC$792
  • Takeda Pharmaceuticals U.S.A., Inc.$785
  • Neos Therapeutics, LP$375
  • Corium, LLC$312
  • Neurocrine Biosciences, Inc.$288
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$5,697100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,699 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$116,057
Medicare patients
316
Services billed
1,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole28$77,660
Lurasidone Hcl34$37,563
TrintellixVortioxetine Hydrobromide18$21,771
Aripiprazole141$12,562
VyvanseLisdexamfetamine Dimesylate16$12,502
Duloxetine Hcl105$5,313
Escitalopram Oxalate248$4,624
Clonazepam579$4,382
Clozapine80$3,836
Adderall XrDextroamphetamine/Amphetamine18$3,836
Fluoxetine Hcl224$3,499
Desvenlafaxine Succinate ErDesvenlafaxine Succinate47$3,415
Bupropion XlBupropion Hcl108$3,380
Quetiapine Fumarate149$2,839
Alprazolam359$2,407

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$1,800$77,66028 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$785$34,27334 claims
Almatica Pharma LLCSertraline Hcl$18$1,796177 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Roslyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →